[ASCO/CAP guidelines and recommendations on hormonal receptor testing in breast cancer]

Zhonghua Bing Li Xue Za Zhi. 2010 Nov;39(11):721-2.
[Article in Chinese]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms / chemistry*
  • Breast Neoplasms / therapy
  • Carcinoma, Intraductal, Noninfiltrating / chemistry
  • Carcinoma, Intraductal, Noninfiltrating / therapy
  • Female
  • Humans
  • Immunohistochemistry
  • Medical Oncology / standards
  • Practice Guidelines as Topic
  • Receptors, Estrogen / analysis*
  • Receptors, Progesterone / analysis*
  • Societies, Medical
  • Tamoxifen / therapeutic use
  • United States

Substances

  • Antineoplastic Agents, Hormonal
  • Receptors, Estrogen
  • Receptors, Progesterone
  • Tamoxifen